How long after exposure should rabies immunoglobulin (Rabies Immune Globulin) be administered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rabies Immunoglobulin Administration Timeline

Rabies immunoglobulin (RIG) should be administered on day 0 (the day the first vaccine dose is given), but if missed, it can still be given up to and including day 7 after the first vaccine dose. 1

Optimal Timing

  • RIG must be administered as soon as possible on day 0 when postexposure prophylaxis is initiated, given in conjunction with the first dose of rabies vaccine. 1

  • The ACIP guidelines explicitly state that if RIG was not administered when vaccination began on day 0, it can be administered up to and including day 7 of the postexposure prophylaxis series. 1

  • Beyond day 7, RIG is not indicated because an antibody response to the cell culture vaccine is presumed to have occurred by that time. 1, 2

Critical Rationale for the Day 7 Cutoff

  • RIG provides immediate passive rabies virus-neutralizing antibody coverage until the patient actively produces antibodies in response to vaccination. 1

  • By day 7-8, vaccine-induced active antibody production is expected to have begun, making passive immunization unnecessary and potentially counterproductive. 1

  • Administering RIG after day 7 can partially suppress active antibody production, which is why it should not be given beyond this timeframe for the same exposure. 1, 3

Administration Details

  • The dose is 20 IU/kg body weight, given only once (not repeated with subsequent vaccine doses). 1, 4, 2

  • As much of the RIG dose as anatomically feasible should be thoroughly infiltrated around and into the wound(s). 1

  • Any remaining volume should be injected intramuscularly at a site distant from vaccine administration. 1

Common Pitfalls to Avoid

  • Never administer RIG in the same syringe or same anatomical site as the first vaccine dose, as this can interfere with vaccine efficacy. 1, 5

  • Do not exceed the recommended 20 IU/kg dose, as higher doses can suppress active antibody production. 1, 3

  • RIG is not indicated for previously vaccinated persons (those who completed a full pre-exposure or postexposure prophylaxis regimen), as it may inhibit the anamnestic response. 1, 2

  • The day 7 deadline applies to the same exposure episode; a new separate exposure occurring after day 7 of an initial series would require its own RIG administration on day 0 of the new exposure. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Post-Exposure Prophylaxis for Rabies in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Rabies Vaccine Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the recommended treatment for a patient who has received post-exposure rabies prophylaxis (Post-Exposure Prophylaxis, PEP) in the last year and suffers a catastrophic scratch?
Can the rabies vaccine be administered 7 days after a bite?
Does an 18-year-old patient who touched a bleeding beaver with an abrasion, but no skin break, and received a tetanus shot, require rabies prophylaxis after getting beaver blood on their face?
What is the recommended course of action for potential rabies exposure in a patient with unexplained animal bite marks?
What is the appropriate treatment for a patient bitten by a stray cat, with a puncture wound and up-to-date tetanus vaccinations, but no prior rabies vaccination?
What is the best course of action for a patient experiencing tachycardia after brain surgery?
What are the mechanisms of action and dosages of GLP-1 (Glucagon-Like Peptide-1) analogs, such as semaglutide (semaglutide) and liraglutide (liraglutide), and SGLT-2 (Sodium-Glucose Linked Transporter-2) inhibitors, such as empagliflozin (empagliflozin) and canagliflozin (canagliflozin), for a patient with type 2 diabetes and a history of pancreatitis or medullary thyroid cancer?
What lifestyle changes and potential complications are associated with unmanaged Hypertension (HTN) and morbid obesity in patients?
What is the recommended management for an asymptomatic patient with 60% carotid stenosis?
How to manage rheumatoid arthritis (RA) in a patient with thrombocytopenia?
What stage of acute kidney injury (AKI) is a patient with pancreatitis experiencing, given an elevated creatinine level from 1.01 to 3.49, indicating impaired renal function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.